Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation.


Journal

Frontiers of medicine
ISSN: 2095-0225
Titre abrégé: Front Med
Pays: China
ID NLM: 101549428

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 14 04 2017
accepted: 30 09 2017
pubmed: 21 4 2018
medline: 19 7 2019
entrez: 21 4 2018
Statut: ppublish

Résumé

Human leukocyte antigen (HLA)-matched donors for hematopoietic stem cell transplantation (HSCT) have long been scarce in China. Haploidentical (haplo) donors are available for the vast majority of patients, but toxicity has limited this approach. Three new approaches for haplo-HSCT originated from Italy, China, and USA in 1990 and have been developed to world-renowned system up to now. The Chinese approach have been greatly improved by implementing new individualized conditioning regimens, donor selection based on non-HLA systems, risk-directed strategies for graft-versus-host disease and relapse, and infection management. Haplo-HSCT has exhibited similar efficacy to HLA-matched HSCT and has gradually become the predominant donor source and the first alternative donor choice for allo-HSCT in China. Registry-based analyses and multicenter studies adhering to international standards facilitated the transformation of the unique Chinese experience into an inspiration for the refinement of global practice. This review will focus on how the new era in which "everyone has a donor" will become a reality in China.

Identifiants

pubmed: 29675688
doi: 10.1007/s11684-017-0595-7
pii: 10.1007/s11684-017-0595-7
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

45-56

Références

Zhonghua Nei Ke Za Zhi. 2001 Nov;40(11):760-3
pubmed: 11930684
Biol Blood Marrow Transplant. 2002;8(3):131-8
pubmed: 11939602
Bone Marrow Transplant. 2002 Dec;30(12):861-6
pubmed: 12476277
Beijing Da Xue Xue Bao Yi Xue Ban. 2003 Apr 18;35(2):115-8
pubmed: 12920822
Chin Med J (Engl). 2004 Apr;117(4):604-7
pubmed: 15109458
Haematologica. 2004 Dec;89(12):1517-24
pubmed: 15590404
Chin Med J (Engl). 2004 Dec;117(12):1778-85
pubmed: 15603704
J Clin Oncol. 2005 May 20;23(15):3447-54
pubmed: 15753458
Haematologica. 2005 May;90(5):715-6
pubmed: 15921400
Bone Marrow Transplant. 2006 Aug;38(4):291-7
pubmed: 16883312
Haematologica. 2007 Mar;92(3):414-7
pubmed: 17339194
Leukemia. 2008 Mar;22(3):593-9
pubmed: 18185520
J Clin Immunol. 2008 May;28(3):276-83
pubmed: 18204965
Biol Blood Marrow Transplant. 2008 Apr;14(4):469-77
pubmed: 18342790
Biol Blood Marrow Transplant. 2008 Jun;14(6):641-50
pubmed: 18489989
Ann Med. 2008;40(6):444-55
pubmed: 18608121
Bone Marrow Transplant. 2009 Jan;43(1):29-36
pubmed: 18776927
Biol Blood Marrow Transplant. 2009 Feb;15(2):257-65
pubmed: 19167686
Bone Marrow Transplant. 2009 Dec;44(11):721-8
pubmed: 19377516
Br J Haematol. 2009 Oct;147(1):43-70
pubmed: 19673883
Biol Blood Marrow Transplant. 2009 Nov;15(11):1376-85
pubmed: 19822296
Blood. 2011 Jan 20;117(3):936-41
pubmed: 20966170
Eur J Immunol. 2011 Feb;41(2):514-26
pubmed: 21268020
Leukemia. 2011 May;25(5):739-48
pubmed: 21274002
Clin Exp Immunol. 2011 Aug;165(2):264-77
pubmed: 21635226
Blood. 2011 Sep 1;118(9):2609-17
pubmed: 21715313
Blood. 2011 Jul 14;118(2):218
pubmed: 21757626
Clin Transplant. 2012 Mar-Apr;26(2):284-91
pubmed: 21919963
Blood. 2011 Dec 1;118(23):6006-17
pubmed: 21921045
Blood. 2012 Apr 5;119(14):3256-62
pubmed: 22337715
J Hematol Oncol. 2012 Mar 18;5:10
pubmed: 22424172
Clin Transplant. 2012 Mar-Apr;26(2):E158-67
pubmed: 22507356
Blood. 2012 Aug 9;120(6):1185-96
pubmed: 22517900
Bone Marrow Transplant. 2012 Dec;47(12):1507-12
pubmed: 22635243
Cancer. 2013 Mar 1;119(5):978-85
pubmed: 23097265
Blood. 2013 Jan 31;121(5):849-57
pubmed: 23165479
Hematology Am Soc Hematol Educ Program. 2012;2012:230-6
pubmed: 23233586
Ann Hematol. 2013 May;92(5):679-87
pubmed: 23274355
Blood. 2013 Jan 31;121(5):719-20
pubmed: 23372150
Bone Marrow Transplant. 2014 Feb;49(2):206-11
pubmed: 24141650
Bone Marrow Transplant. 2014 Mar;49(3):426-33
pubmed: 24292519
Bone Marrow Transplant. 2014 Jul;49(7):873-9
pubmed: 24566712
Biol Blood Marrow Transplant. 2014 Aug;20(8):1176-82
pubmed: 24747336
Bone Marrow Transplant. 2014 Aug;49(8):1070-5
pubmed: 24887381
Leukemia. 2015 Feb;29(2):396-405
pubmed: 24897508
Blood. 2014 Aug 7;124(6):843-50
pubmed: 24916508
J Transl Med. 2014 Jul 01;12:187
pubmed: 24984576
Chin Med J (Engl). 2014;127(14):2583-7
pubmed: 25043071
Blood. 2014 Aug 7;124(6):827-8
pubmed: 25104858
Biol Blood Marrow Transplant. 2014 Dec;20(12):1932-9
pubmed: 25109850
Blood. 2014 Oct 23;124(17):2735-43
pubmed: 25214441
Biol Blood Marrow Transplant. 2015 Jan;21(1):119-29
pubmed: 25300871
Am J Hematol. 2015 Jan;90(1):E9-E16
pubmed: 25303038
Blood Rev. 2015 Mar;29(2):63-70
pubmed: 25307958
Int J Hematol. 2015 Jan;101(1):75-82
pubmed: 25352358
Leukemia. 2015 May;29(5):1069-75
pubmed: 25434302
Bone Marrow Transplant. 2015 Apr;50(4):601-3
pubmed: 25599162
Blood. 2015 May 14;125(20):3173-82
pubmed: 25769621
Clin Transplant. 2015 Jun;29(6):523-30
pubmed: 25809115
Biol Blood Marrow Transplant. 2015 Jun;21(6):1117-26
pubmed: 25840339
Biol Blood Marrow Transplant. 2015 Aug;21(8):1495-505
pubmed: 25921715
Blood. 2015 Jun 18;125(25):3956-62
pubmed: 25940714
J Transl Med. 2015 May 07;13:145
pubmed: 25948100
Eur J Immunol. 2015 Aug;45(8):2396-408
pubmed: 25952732
Eur J Haematol. 2016 Mar;96(3):297-308
pubmed: 26010204
Biol Blood Marrow Transplant. 2015 Nov;21(11):1939-47
pubmed: 26116088
J Hematol Oncol. 2015 Jul 10;8:84
pubmed: 26156584
Nat Rev Clin Oncol. 2016 Jan;13(1):10-24
pubmed: 26305035
Biol Blood Marrow Transplant. 2016 Jan;22(1):23-6
pubmed: 26551633
Br J Haematol. 2016 Jan;172(2):187-207
pubmed: 26568159
Bone Marrow Transplant. 2016 Mar;51(3):391-7
pubmed: 26691421
Clin Cancer Res. 2016 Jul 15;22(14):3467-76
pubmed: 26927664
J Hematol Oncol. 2016 Mar 15;9:25
pubmed: 26980295
Oncotarget. 2016 May 31;7(22):32579-91
pubmed: 27081039
J Clin Oncol. 2016 Jun 1;34(16):1855-63
pubmed: 27091717
Leukemia. 2016 Oct;30(10):2055-2063
pubmed: 27133816
Bone Marrow Transplant. 2016 Nov;51(11):1470-1475
pubmed: 27322852
Bone Marrow Transplant. 2016 Nov;51(11):1464-1469
pubmed: 27322853
Br J Haematol. 2016 Oct;175(2):265-274
pubmed: 27352174
J Clin Oncol. 2016 Aug 20;34(24):2843-50
pubmed: 27400949
Oncoimmunology. 2016 Mar 10;5(5):e1139274
pubmed: 27467959
Sci China Life Sci. 2016 Nov;59(11):1139-1148
pubmed: 27535422
J Hematol Oncol. 2016 Sep 15;9(1):87
pubmed: 27629395
Oncotarget. 2016 Nov 29;7(48):78773-78786
pubmed: 27705929
Int J Hematol. 2016 Dec;104(6):720-728
pubmed: 27709450
J Hematol Oncol. 2017 Jan 19;10(1):24
pubmed: 28103944
J Hematol Oncol. 2017 Jan 21;10(1):25
pubmed: 28107815
Bone Marrow Transplant. 2017 Jun;52(6):811-817
pubmed: 28287639
Cancer. 2017 Aug 1;123(15):2881-2892
pubmed: 28301690
Oncoimmunology. 2017 Feb 6;6(3):e1284721
pubmed: 28405514
Bone Marrow Transplant. 2017 Nov;52(11):1512-1518
pubmed: 28436973
Biol Blood Marrow Transplant. 2017 Aug;23(8):1311-1319
pubmed: 28483716
J Hematol Oncol. 2017 May 30;10(1):113
pubmed: 28558762
Bone Marrow Transplant. 2017 Sep;52(9):1253-1260
pubmed: 28581464
Blood. 2017 Aug 3;130(5):677-685
pubmed: 28588018
Leukemia. 2018 Feb;32(2):492-498
pubmed: 28642591
J Clin Oncol. 2017 Sep 10;35(26):3002-3009
pubmed: 28644773
Blood. 1994 Dec 1;84(11):3948-55
pubmed: 7524753
J Clin Oncol. 1997 May;15(5):1767-77
pubmed: 9164184
N Engl J Med. 1998 Oct 22;339(17):1186-93
pubmed: 9780338

Auteurs

Meng Lv (M)

Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, 100044, China.

Yingjun Chang (Y)

Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, 100044, China.

Xiaojun Huang (X)

Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, 100044, China. huangxiaojun@bjmu.edu.cn.
Peking-Tsinghua Center for Life Sciences, Beijing, 100044, China. huangxiaojun@bjmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH